OneProjects — an Irish-German cardiac imaging startup — announced today that it has raised $12 million (€11 million) in a Series A round.
LSP, based in the Netherlands, investing from its LSP Health Economics Fund 2, and the Atlantic Bridge University Fund (Ireland), led the round, with participation from Enterprise Ireland and a selection of medtech entrepreneurs.
OneProjects, founded in 2017 by CEO Fionn Lahart and CTO Christoph Hennersperger founded OneProjects in 2017 in Dublin Ireland, with significant development activities taking place in Munich, Germany. The company’s Verafeye technology is able to provide 4D data from within the heart, with a goal of increasing the efficacy and safety of atrial fibrillation treatment people around the world.
OneProjects officials plan to use the $12 million to advance product development, carry out clinical trials, and prepare for U.S. commercialization of the system.
“This investment will help us to further build our team in Dublin and Munich, advance product development and ultimately achieve our goal of helping physicians provide a far better treatment for patients suffering from AFib,” Lahart said in a news release.